Clinical Trial Update: Evaluation of the Pharmacokinetics of Microdose Midazolam, Dabigatran, Pitavastatin, Atorvastatin and Rosuvastatin in Diabetic Patients [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating pharmacokinetics of several statins and other drugs in diabetic patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• Dabigatran (Dabigatran etexilate)
• Midazolam (Midazolam)
• Pitavastatin (Pitavastatin)
• Rosuvastatin (rosuvastatin)
• atorvastatin (atorvastatin)

Snippet

Sponsor: Peking University Third Hospital | Conditions: Diabetes | Phase 4 | Status: UNKNOWN